
Extraneal (icodextrin 7.5%) Peritoneal Dialysis Solution has been approved for Baxter Healthcare Corp., Deerfield, Ill., (847) 948-2000. It is indicated for a single daily exchange for the long dwell during continuous ambulatory peritoneal dialysis or automated peritoneal dialysis for the management of end-stage renal disease. It is also indicated to improve long-dwell ultrafiltration and clearance of creatinine and urea nitrogen in patients with high average or greater transport characteristics, as defined by the peritoneal equilibration test.